Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

Everest’s In-licensed Kidney Drug Meets Endpoints in Phase III Trial
Bio-Thera Starts Phase I Trial of Nectin-4 ADC for Solid Tumors
Luye Enrolls Last Patient in Phase III Trial of Eylea Biosimilar
AusperBio Starts New Zealand Phase I Trial of Novel Therapy for CHB
Ambrx Partner Says HER2 ADC Ups Progression-Free Survival in Breast Cancer Trial
ChinaBio Event
Singapore and Digital
April 26-27, 2023
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China